Skip to search formSkip to main contentSkip to account menu

SKI 2053R

Known as: SKI-2053R 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

MalonatesOrganometallic CompoundsOrganoplatinum Compounds

Narrower (1)

heptaplatin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Combined effect of heptaplatin and ionizing radiation on human squamous carcinoma cell lines.
2003
2003
Pilot Study of Heptaplatin, UFT-E and Leucovorin in Advanced Gastric Carcinoma.
PURPOSE Heptaplatin (SKI-2053R, Sunpla ), a new platinum analogue which has a better toxicity profile than cisplatin, has been… 
2003
2003
Study of Effects of SKI-2053R Inhibiting Proliferation of Gastric Carcinoma Cell Line
Objective To study the effect of SKI-2053R on SGC-7901 cell line.Methods MTT assay was used to test the effects of SKI-2053R on… 
1999
1999
Phase II clinical trial of SKI‐2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma
SKI‐2053R (SK Chemicals, Kyungki‐Do, South Korea) is a new platinum derivative with antitumor activity against various cell lines… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)